Notable Tuesday Option Activity: AMZN, ASTH, WDAY

Unusually high options activity was recorded in Astrana Health (ASTH) and Workday (WDAY): ASTH saw 5,411 contracts trade (≈541,100 underlying shares, ~83.8% of ASTH's 1-month average daily volume of 645,870), driven by 5,397 contracts in the $30 call expiring Jan 16, 2026 (≈539,700 shares). WDAY registered 18,509 contracts (≈1.9M underlying shares, ~72.3% of its 1-month average daily volume of 2.6M), led by 1,786 contracts in the $207.50 put expiring Nov 28, 2025 (≈178,600 shares). The concentrated strikes and expiries point to notable speculative positioning that could raise near-term volatility and influence short-term price action in both names.

Analysis

Market structure: Concentrated option flow — ASTH ~5,397 Jan‑2026 $30 calls (~539.7k shares, ~83.8% of ADV) and WDAY ~1,786 Nov‑2025 $207.50 puts (~178.6k shares, ~72.3% of ADV) — implies one‑sided demand that will push short‑dated implied vol and force dealer delta hedging. Winners in the short run are directional buyers of ASTH calls and holders of WDAY puts (and market makers capturing elevated IV); losers are uninformed liquidity sellers and any index/ETF holders exposed to sudden re‑pricing. Expect 1–4 week directional gamma flows to dominate price moves, with potential IV rise of ~5–20% in near‑dated expiries.

Risk assessment: Immediate (days) tail risk: concentrated trades represent block positions that can unwind violently if the initiating counterparty reduces exposure; short‑term (weeks–months) risks include FDA/clinical data for ASTH or enterprise spending revisions affecting WDAY; long‑term (quarters) fundamentals still matter and could negate flow‑driven moves. Hidden dependencies: a single large institutional buyer, index rebalance, or seller of hedge protection could flip market maker hedging from buy to sell. Catalysts: ASTH clinical/regulatory calendar and WDAY fiscal updates/large customer churn announcements within next 3–9 months.

Trade implications: Direct plays — establish a small, option‑based exposure rather than leverage to shares. For ASTH consider purchasing Jan‑16‑2026 $30 calls as a 0.5% portfolio position (or a 30/45 call vertical to cap premium) and scale out on a 30–50% gain; for WDAY buy Nov‑28‑2025 $207.50 puts as a 0.5% hedge or initiate a short position sized to be closed if price rises +10%. Pair trade — long ASTH Jan‑2026 $30C (0.5%) vs short WDAY equity (0.5%) to isolate idiosyncratic flow. Act within 3–10 trading days while flows persist; set stop losses at 30% premium loss or 10% move against underlying.

Contrarian angles: The market may be misreading block flow as broad conviction — a single buyer can create transient price effects that reverse when hedges unwind. Historical parallels include biotech call clusters ahead of buyout rumors that often faded; conversely, some led to true M&A. Watch for SEC 13D/G filings, large block trade prints, and term‑structure shifts (near‑term IV >> long‑term IV) as the real signal — if near IV collapses >20% without fundamental news, fade the initial directional move within 2–6 weeks.

Key Decisions for Investors

• Establish a tactical 0.5% portfolio notional long in ASTH via Jan‑16‑2026 $30 call purchase or a 30/45 call debit spread to limit premium; target 30–50% realized premium gain, stop at 30% premium loss; enter within 3–10 days while flow persists.
• Hedge enterprise‑software downside with a 0.5% notional purchase of WDAY Nov‑28‑2025 $207.50 puts (or a 207.5/165 put spread to cap cost); close if WDAY rallies >10% or if puts decline 30% from entry.
• Initiate a pair trade: long ASTH Jan‑2026 $30C (0.5%) financed by shorting WDAY equity equal dollar (0.5%) to isolate idiosyncratic moves; unwind if pair P/L hits +25% or -15% or after the next major catalyst (earnings/FDA) within 3–9 months.
• Monitor immediately (next 72 hours) for SEC 13D/G filings, block trade prints, and >15% shifts in 30‑ vs 180‑day IV; if any appear, increase vigilance: trim positions by 50% upon confirmation of a single‑counterparty trade or on IV contraction >20%.